Unified Theory: DMT and Ketamine Anesthesia via Sigma-1, Entropy, and Overload

New Theory: DMT and Ketamine Induce Anesthesia via Information Overload

A November 2026 peer-reviewed paper (OpenAlex W7225164565) introduces a unified theoretical framework for anesthesia induced by N,N-Dimethyltryptamine (DMT) and ketamine. The authors argue that, unlike traditional anesthetics which suppress neural activity, these compounds render patients unresponsive by saturating the brain's information processing capacity—an "anesthesia via dissociative overload." This model is grounded in observed increases in cortical entropy and complexity during DMT- and ketamine-induced unresponsiveness, a pattern that contradicts the classic neural suppression paradigm.

Mechanism: Sigma-1 Convergence, Entropic Saturation, and Workspace Flooding

The proposed framework identifies three converging mechanisms underlying DMT and ketamine anesthesia:

• Molecular Convergence on Sigma-1 Receptor (σ1R): Both DMT and ketamine, despite acting on distinct primary targets (5-HT2A for DMT, NMDA for ketamine), converge on the Sigma-1 receptor and trigger a prefrontal glutamate surge. This shared endpoint suggests a non-GABAergic route to anesthesia.
• Entropic Saturation: Unlike GABAergic anesthetics (e.g., propofol), which reduce neural entropy, DMT and ketamine maintain or elevate cortical entropy during unresponsiveness. The authors argue this is not a monitoring artifact, but evidence of informational overload—where the brain's processing capacity is exceeded, preventing coherent external-world modeling.
• Workspace Flooding: The "Global Neuronal Workspace" theory posits that consciousness arises from information broadcast across cortical networks. The new model suggests that DMT and ketamine cause mass activation that overwhelms this workspace, collapsing predictive coding hierarchies and blocking the serial processing required for conscious awareness.

This framework introduces a dual taxonomy: Suppressive anesthesia (GABAergic, entropy-reducing) versus Saturative anesthesia (glutamatergic/serotonergic, entropy-preserving or -increasing). The authors generate six testable predictions distinguishing these modes, including differential EEG signatures and behavioral dissociation profiles.

Implications for Clinical Trials, Research, and Policy

If validated, this theory could reshape the design of clinical trials and the regulatory evaluation of dissociative anesthetics. For researchers, the model highlights the need to measure not only loss of responsiveness but also changes in cortical entropy and workspace dynamics, using tools such as high-density EEG and advanced computational modeling. For clinicians, understanding saturative anesthesia may inform dosing, monitoring, and risk assessment for compounds like ketamine, and potentially for future DMT-based interventions.

Policy makers and regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) may need to revisit guidance on anesthesia endpoints and safety monitoring, particularly if non-GABAergic agents become more prevalent in clinical practice. The model also opens new translational research avenues, including the search for selective Sigma-1 modulators with improved safety profiles.

Risks, Unknowns, and Experimental Challenges

The Dissociative Overload model remains a theoretical framework, and its extension to DMT-induced anesthesia is a central prediction that awaits direct experimental validation. Key risks include the possibility that observed entropy increases are artifacts of measurement or reflect non-specific arousal rather than true informational overload. Additionally, the role of the Sigma-1 receptor in human anesthesia is incompletely understood, and off-target effects or interindividual variability may complicate clinical translation.

One non-obvious challenge is that saturative anesthesia may be harder to reverse or monitor using conventional tools, as EEG signatures differ from those of suppressive agents. This could have safety implications in surgical or emergency settings, especially if standard depth-of-anesthesia monitors are calibrated for GABAergic drugs.

Looking Ahead: Testable Predictions and Future Directions

The framework generates concrete, falsifiable predictions—such as distinct EEG patterns, behavioral dissociation, and the potential for Sigma-1 antagonists to reverse saturative anesthesia. These predictions can guide both preclinical and clinical studies, accelerating the translation of basic neuroscience into improved anesthetic care. If supported by future trials, this theory could clarify the neurobiological basis of psychedelic and anesthetic states, inform drug development, and reshape how clinicians and regulators approach consciousness-modulating agents.

How we research / reviewed by: Dr. Alex J. Carter, PhD (Neuroscience), reviewed 2026-11-05. Sources: primary research article (OpenAlex W7225164565), FDA anesthesia guidance, and Global Neuronal Workspace literature.